Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells

Fenfluramine is prescribed either alone or in combination with phentermine as part of Fen-Phen, an anti-obesity medication. Fenfluramine was withdrawn from the US market in 1997 due to reports of heart valvular disease, pulmonary arterial hypertension, and cardiac fibrosis. Particularly, idiopathic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Yao, Weijuan, Mu, Wenbo, Zeifman, Amy, Lofti, Michelle, Remillard, Carmelle V., Makino, Ayako, Perkins, David L., Garcia, Joe G., Yuan, Jason X. J., Zhang, Wei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Medknow Publications & Media Pvt Ltd 2011
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3224433/
https://ncbi.nlm.nih.gov/pubmed/22140631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2045-8932.87310
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller